QQ客服 官方微博 反馈留言

	A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia
	Liu, Yang; Zhang, Yingyuan*; Wu, Jufang; Zhu, Demei; Sun, Shenghua; Zhao, Li; Wang, Xuefeng; Liu, Hua; Ren, Zhenyi; Wang, Changzheng
刊名	Journal of Microbiology, Immunology and Infection
	2017
卷号	50期号:6页码:811-820
关键词	clinical trial community-acquired pneumonia efficacy nenomoxacin safety
ISSN号	1684-1182
DOI	10.1016/j.jmii.2015.09.005
URL标识	查看原文
WOS记录号	WOS:000418085100009
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3342659
专题	中南大学
作者单位	1.[Zhang, Yingyuan 2.Wu, Jufang 3.Liu, Yang 4.Zhu, Demei] Fudan Univ, Huashan Hosp, Inst Antibiot, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.
推荐引用方式 GB/T 7714	Liu, Yang,Zhang, Yingyuan*,Wu, Jufang,et al. A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia[J]. Journal of Microbiology, Immunology and Infection,2017,50(6):811-820.
APA	Liu, Yang.,Zhang, Yingyuan*.,Wu, Jufang.,Zhu, Demei.,Sun, Shenghua.,...&Chang, Liwen.(2017).A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia.Journal of Microbiology, Immunology and Infection,50(6),811-820.
MLA	Liu, Yang,et al."A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia".Journal of Microbiology, Immunology and Infection 50.6(2017):811-820.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。